While Rybelsus is not a weight loss medication, the same study saw participants weighing over 200 pounds lose an average of 5 to 8 pounds
Kamel Dr
A GLP-1 blocker acts by inhibiting the GLP-1 receptor, which modulates the downstream inflammatory pathways linked to: cytokine production immune system activation oxidative stress inflammatory signaling in tissues such as the liver, fat cells, and gut In low doses, blocking GLP-1 receptors appears to influence the immune system without significantly interfering with glucose control which is why this approach is being studied specifically for inflammation rather than metabolic disease
Results May Vary: Individual results vary based on factors including age, baseline health, cardiovascular status, current medications, consistency of use, genetic factors, and other individual variables
247 USDA (2016a)
The animals were divided into three groupsthe CON, TS, and GABA groups (each with n = 8)